You have 9 free searches left this month | for more free features.

City

Condition

Hepatitis C (2)

Hepatitis C, Chronic (1)

Overall Status

Completed (3)

Sign in for free

Phase

phase 2 (2)

phase 1 (1)

Sponsor

Merck Sharp & Dohme LLC (3)

Collaborator

Intervention

ruzasvir (3)

uprifosbuvir (3)

elbasvir (2)

grazoprevir (2)

mk-3682b (1)

ribavirin (1)

ribavirin (rbv) (1)

uprifosbuvir (+) grazoprevir (+) ruzasvir (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

uprifosbuvir

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Hepatitis C Trial (Grazoprevir, Uprifosbuvir, Elbasvir)

Completed

Has Results

Hepatitis C

Grazoprevir
+5 more

(no location specified)

Jul 10, 2019

Hepatitis C Trial (Grazoprevir, Uprifosbuvir, Elbasvir)

Completed

Has Results

Hepatitis C

Grazoprevir
+5 more

(no location specified)

Jul 18, 2019

Hepatitis C, Chronic Trial (Uprifosbuvir, Ruzasvir)

Completed

Has Results

Hepatitis C, Chronic

Uprifosbuvir
Ruzasvir

(no location specified)

Jan 11, 2018